Falcone Mary, Salhia Bodour, Hughes Halbert Chanita, Roussos Torres Evanthia T, Stewart Daphne, Stern Mariana C, Lerman Caryn
USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, California.
Cancer Res. 2024 Dec 2;84(23):3924-3935. doi: 10.1158/0008-5472.CAN-24-1359.
The striking ethnic and racial disparities in breast cancer mortality are not explained fully by pathologic or clinical features. Structural racism contributes to adverse conditions that promote cancer inequities, but the pathways by which this occurs are not fully understood. Social determinants of health, such as economic status and access to care, account for a portion of this variability, yet interventions designed to mitigate these barriers have not consistently led to improved outcomes. Based on the current evidence from multiple disciplines, we describe a conceptual model in which structural racism and racial discrimination contribute to increased mortality risk in diverse groups of patients by promoting adverse social determinants of health that elevate exposure to environmental hazards and stress; these exposures in turn contribute to epigenetic and immune dysregulation, thereby altering breast cancer outcomes. Based on this model, opportunities and challenges arise for interventions to reduce racial and ethnic disparities in breast cancer mortality.
乳腺癌死亡率方面显著的种族和民族差异并不能完全由病理或临床特征来解释。结构性种族主义导致了促进癌症不平等的不利状况,但其发生的途径尚未完全明了。健康的社会决定因素,如经济状况和获得医疗服务的机会,解释了这种差异的一部分,但旨在减轻这些障碍的干预措施并未始终带来更好的结果。基于多学科的现有证据,我们描述了一个概念模型,其中结构性种族主义和种族歧视通过促进不良的健康社会决定因素,增加了不同患者群体的死亡风险,这些因素会增加对环境危害和压力的暴露;这些暴露反过来又导致表观遗传和免疫失调,从而改变乳腺癌的预后。基于这个模型,减少乳腺癌死亡率方面种族和民族差异的干预措施面临着机遇和挑战。